Black Rock Inc. Savara Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Savara Inc stock. As of the latest transaction made, Black Rock Inc. holds 8,030,614 shares of SVRA stock, worth $32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,030,614

Previous 7,241,815 10.89%

Holding current value

$32 Million

Previous $36.1 Million 10.26%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.66 - $5.34 $2.89 Million - $4.21 Million	788,799 Added 10.89%	8,030,614 $32.4 Million
Q1 2024 May 10, 2024	SELL	$4.19 - $5.59 $82,605 - $110,206	-19,715 Reduced 0.27%	7,241,815 $36.1 Million
Q4 2023 Feb 13, 2024	BUY	$3.18 - $4.9 $3.89 Million - $5.99 Million	1,221,803 Added 20.23%	7,261,530 $34.1 Million
Q3 2023 Nov 13, 2023	BUY	$2.97 - $3.88 $3.39 Million - $4.43 Million	1,141,151 Added 23.3%	6,039,727 $22.8 Million
Q2 2023 Aug 11, 2023	BUY	$1.69 - $3.24 $6.51 Million - $12.5 Million	3,854,198 Added 369.04%	4,898,576 $15.6 Million
Q1 2023 May 12, 2023	BUY	$1.6 - $2.82 $7,238 - $12,757	4,524 Added 0.44%	1,044,378 $2.04 Million
Q4 2022 Feb 13, 2023	BUY	$1.11 - $1.64 $7,082 - $10,464	6,381 Added 0.62%	1,039,854 $1.61 Million
Q3 2022 Nov 14, 2022	SELL	$1.36 - $1.88 $4,424 - $6,115	-3,253 Reduced 0.31%	1,033,473 $1.6 Million
Q2 2022 Aug 12, 2022	SELL	$1.1 - $1.58 $3,907 - $5,612	-3,552 Reduced 0.34%	1,036,726 $1.58 Million
Q1 2022 May 12, 2022	SELL	$1.05 - $1.36 $8,364 - $10,833	-7,966 Reduced 0.76%	1,040,278 $1.36 Million
Q4 2021 Feb 10, 2022	BUY	$1.04 - $1.34 $2,548 - $3,283	2,450 Added 0.23%	1,048,244 $1.3 Million
Q3 2021 Nov 09, 2021	SELL	$1.18 - $1.64 $3,352 - $4,659	-2,841 Reduced 0.27%	1,045,794 $1.44 Million
Q2 2021 Aug 11, 2021	BUY	$1.51 - $2.29 $1.58 Million - $2.4 Million	1,048,635 New	1,048,635 $1.78 Million

Others Institutions Holding SVRA

# of Institutions

145

Shares Held

147M

Call Options Held

280K

Put Options Held

798K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $455M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account